The Billion-Dollar Molecule
| File:The Billion Dollar Molecule-large.jpg
Paperback edition
|
|
| Author | Barry Werth |
|---|---|
| Country | United States |
| Language | English |
| Subject | Biotechnology |
| Genre | Non-fiction |
| Publisher | Simon & Schuster |
|
Publication date
|
February 16, 1994 |
| Pages | 448 pp. (hardcover) |
| ISBN | 0-671-51057-6 |
The Billion-Dollar Molecule is a book[1] by journalist Barry Werth about the founding and early research efforts of the American biotechnology company Vertex Pharmaceuticals, which was founded in 1989 by Joshua Boger and was among the first biotechnology companies to adopt an explicit strategy of rational drug design as opposed to techniques based on combinatorial chemistry.
This book is notable as an inside look at a biotechnology company, and the stresses and marketing pressures on funding research into drug design. This book is a mixture of finance and technology.
In February, 2014, Barry Werth published a follow-on book, The Antidote,[2] that looks at Vertex 20 years later after his original effort.[3]
References
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ http://www.barrywerth.com retrieved 2014-01-01
 Pharmaceutical industry in the United States |
|
|---|---|
| Companies | |
| Regulatory bodies | |
| Professional bodies | |
| Miscellaneous | |
| Books |
|
| Lists | |
| Related templates | |
| Related categories | |
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This article about a book on a company or brand is a stub. You can help Wikipedia by expanding it. |
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This article about a chemistry-related book is a stub. You can help Wikipedia by expanding it. |
